50 Recruiting Thyroid Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Thyroid Cancer Studies
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
📍 University of Chicago Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Study of PET Imaging With 18F-TFB in Patients With Thyroid Cancer
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of Optical Imaging With Light From Radiotracers in Cancer Patients
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Measuring Patient Expectations for Thyroid Surgery
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer
📍 Cleveland Clinic — Cleveland, Ohio
View Study & Checklist ➔Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
View Study & Checklist ➔RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer
📍 Gustave Roussy — Villejuif, Val de Marne
View Study & Checklist ➔177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Hereditary Risk Factors for Thyroid Cancer
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
📍 MedStar Washington Hospital Center — Washington D.C., District of Columbia
View Study & Checklist ➔The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
📍 Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
View Study & Checklist ➔Personalized Treatment in Thyroid Disorders
📍 Johns Hopkins Hospital — Baltimore, Maryland
View Study & Checklist ➔I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer
📍 Miami Cancer Research Center — North Miami, Florida
View Study & Checklist ➔Environmental Factors and Thyroid Cancer
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.
📍 Hospital Alma Mater de Antioquia — Medellín, Antioquia
View Study & Checklist ➔Assessing Patient Satisfaction and Confidence After Use of Educational Video to Augment Surgical Consent for Thyroid Surgery
📍 Thomas Jefferson University — Philadelphia, Pennsylvania
View Study & Checklist ➔Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Study of Avutometinib and Defactinib in People With Thyroid Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔